Profound, which builds marketing software to help brands appear in AI search results, on Tuesday said it has raised a $180 million Series D at a $1.8 billion valuation, less than seven months after it raised a $96 million Series C.
Up to $35 million from the Gates Foundation will support ProFound’s use of its platform, datasets, and algorithms to identify new drug targets and biomarkers for preeclampsia and eclampsia
